1. Home
  2. USNA vs EYPT Comparison

USNA vs EYPT Comparison

Compare USNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$20.49

Market Cap

362.9M

Sector

Health Care

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.10

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
EYPT
Founded
1992
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
362.9M
1.5B
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
USNA
EYPT
Price
$20.49
$16.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$36.00
$29.60
AVG Volume (30 Days)
173.0K
1.1M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$912,670,000.00
$42,339,000.00
Revenue This Year
$9.87
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.73
N/A
Revenue Growth
5.88
N/A
52 Week Low
$18.48
$3.91
52 Week High
$38.32
$19.11

Technical Indicators

Market Signals
Indicator
USNA
EYPT
Relative Strength Index (RSI) 52.61 60.28
Support Level $19.33 $15.97
Resistance Level $21.11 $19.11
Average True Range (ATR) 0.60 0.96
MACD 0.25 0.11
Stochastic Oscillator 66.40 46.36

Price Performance

Historical Comparison
USNA
EYPT

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: